Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Wino115


T.TH

RE:RE:Just a reminder for the last bit of 1a protocol

It was posted here last week by someone. There was a bit of confusion around...

February 2, 2022

T.TH

Just a reminder for the last bit of 1a protocol

It's looking like March to me for MTD. The end ultimately needs to have...

February 1, 2022

T.TH

RE:RE:RE:The phase 1a trial has already been de-risked

Barring any clear sign of efficacy, I would take data around the proof of...

February 1, 2022

T.TH

RE:RE:RE:The phase 1a trial has already been de-risked

It will be an indication if any of the conferences and investor calls PL...

January 31, 2022

T.TH

RE:RE:The phase 1a trial has already been de-risked

I don't disagree, but I did notice that Sutro recently disappointed with...

January 31, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:MDGL Update

Here's a firm that creates peptide siRNA conjugates and the ADC versions...

January 31, 2022

T.TH

RE:RE:MDGL Update

What the NASH space needs to see -- a successful leader moving to approvall. ...

January 31, 2022

T.TH

RE:RE:RE:RE:Encouraging

You know I'm not a science guy up here, but my limited understanding is...

January 28, 2022

T.TH

RE:RE:RE:Encouraging

Would they bother hiring scientist at the cutting edge around ways to...

January 28, 2022

T.TH

RE:RE:RE:RE:RE:Hostile or friendly I’ll take it too

We're all feeling very, very old....!  One thing I think Paul knows,...

January 28, 2022

T.TH

RE:RE:Hostile or friendly I’ll take it too

Of course, anything can happen, but from what I see, Paul seems to be a...

January 28, 2022

T.TH

RE:RE:Gilead oncology franchise small setback w/Magrolimab

It's an interseting conundrum. Darned if you do and darned if you don'...

January 26, 2022

T.TH

Observation - Audience Building?

One unique observation the Grumpy Grader latched on to was the Stockwits # of...

January 26, 2022

T.TH

Gilead oncology franchise small setback w/Magrolimab

They bought the company behind magrolimab for $4.9bil in 2020. Not working...

January 25, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:Feedback from Today's Meeting with Large Shareholders

If it's a traditional offering with a decent number of brokers, yes...

January 25, 2022

T.TH

RE:RE:RE:RE:RE:RE:Feedback from Today's Meeting with Large Shareholders

Forgot, you can do the final round of IR interviewing too.  I'm sure...

January 25, 2022

T.TH

RE:RE:RE:RE:RE:Feedback from Today's Meeting with Large Shareholders

Those sort of roadshows happen. You are right that it usually includes a...

January 25, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:The No News Surprise

My recollection is that was the original date for the entire Phase 1 (a+b) to...

January 24, 2022

T.TH

RE:RE:RE:RE:The No News Surprise

Yes, the science and the milestones are what will be defining moments for...

January 24, 2022

T.TH

RE:RE:Really bizarre

I suppose these are Montreal Mafia codewords to get in to all the great...

January 23, 2022

Featured Company